Technology: CAR-T, Cell-based gene therapy
Industry: CAR-T, Public
Headquarters: Florham Park, New Jersey, United States
Founded Date: 2017-09-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 12
Total Funding: 400000011
Estimated Revenue: $50M to $100M
Last Funding Date: 2022-05-26
Last Funding Type: Post-IPO Equity

Visit Website
media@celularity.com
https://twitter.com/celularity
Register and Claim Ownership